Cipher Pharma (CPHR) Misses Q1 EPS by 6c
Get Alerts CPHR Hot Sheet
Join SI Premium – FREE
Cipher Pharma (NASDAQ: CPHR) reported Q1 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $10.72 million.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!